SYNLOGIC, INC. Other Current Assets
SYNLOGIC, INC. (SYBX) had Other Current Assets of $42.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-08-11
- 2026-06-30: Other Assets, Current $42.00K.
- 2026-03-31: Other Assets, Current $43.00K.
- 2025-12-31: Other Assets, Current $48.00K.
- 2025-09-30: Other Assets, Current $55.00K.
| Period end | Other Assets, Current |
|---|---|
| 2026-06-30 | $42.00K 10-Q · filed 2026-08-11 |
| 2026-03-31 | $43.00K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $48.00K 10-Q · filed 2026-08-11 |
| 2025-09-30 | $55.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $59.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $63.00K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $75.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $156.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $353.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $111.00K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $146.00K 10-K · filed 2025-03-06 |
| 2022-12-31 | $175.00K 10-K · filed 2024-03-19 |
| 2021-12-31 | $311.00K 10-K · filed 2023-03-29 |
| 2020-12-31 | $247.00K 10-K · filed 2022-03-17 |
| 2019-12-31 | $648.00K 10-K · filed 2021-03-25 |
| 2019-09-30 | $522.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $2.53M 10-Q · filed 2019-08-08 |
| 2018-12-31 | $388.00K 10-K · filed 2020-03-12 |
| 2017-12-31 | $298.00K 10-K · filed 2019-03-12 |
| 2017-09-30 | $194.00K 10-Q · filed 2017-11-13 |
| 2016-12-31 | $31.00K 10-K · filed 2018-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |